Identification of treatment error types for lung cancer patients using convolutional neural networks and EPID dosimetry
- PMID: 33011206
- DOI: 10.1016/j.radonc.2020.09.048
Identification of treatment error types for lung cancer patients using convolutional neural networks and EPID dosimetry
Abstract
Background/purpose: Electronic portal imaging device (EPID) dosimetry aims to detect treatment errors, potentially leading to treatment adaptation. Clinically used threshold classification methods for detecting errors lead to loss of information (from multi-dimensional EPID data to a few numbers) and cannot be used for identifying causes of errors. Advanced classification methods, such as deep learning, can use all available information. In this study, convolutional neural networks (CNNs) were trained to detect and identify error type and magnitude of simulated treatment errors in lung cancer patients. The purpose of this simulation study is to provide a proof-of-concept of CNNs for error identification using EPID dosimetry in an in vivo scenario.
Materials and methods: Clinically realistic ranges of anatomical changes, positioning errors and mechanical errors were simulated for lung cancer patients. Predicted portal dose images (PDIs) containing errors were compared to error-free PDIs using the widely used gamma analysis. CNNs were trained to classify errors using 2D gamma maps. Three classification levels were assessed: Level 1 (main error type, e.g., anatomical change), Level 2 (error subtype, e.g., tumor regression) and Level 3 (error magnitude, e.g., >50% tumor regression).
Results: CNNs showed good performance for all classification levels (training/test accuracy 99.5%/96.1%, 92.5%/86.8%, 82.0%/72.9%). For Level 3, overfitting became more apparent.
Conclusion: This simulation study indicates that deep learning is a promising powerful tool for identifying types and magnitude of treatment errors with EPID dosimetry, providing additional information not currently available from EPID dosimetry. This is a first step towards rapid, automated models for identification of treatment errors using EPID dosimetry.
Keywords: Artificial intelligence; Deep learning; EPID dosimetry; Error identification; In vivo dosimetry; Treatment verification.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
A novel approach to SBRT patient quality assurance using EPID-based real-time transit dosimetry : A step to QA with in vivo EPID dosimetry.Strahlenther Onkol. 2020 Feb;196(2):182-192. doi: 10.1007/s00066-019-01549-z. Epub 2020 Jan 10. Strahlenther Onkol. 2020. PMID: 31925465
-
In vivo EPID-based daily treatment error identification for volumetric-modulated arc therapy in head and neck cancers with a hierarchical convolutional neural network: a feasibility study.Phys Eng Sci Med. 2024 Sep;47(3):907-917. doi: 10.1007/s13246-024-01414-z. Epub 2024 Apr 22. Phys Eng Sci Med. 2024. PMID: 38647634
-
External validation of a hidden Markov model for gamma-based classification of anatomical changes in lung cancer patients using EPID dosimetry.Med Phys. 2020 Oct;47(10):4675-4682. doi: 10.1002/mp.14385. Epub 2020 Aug 4. Med Phys. 2020. PMID: 32654162
-
A literature review of electronic portal imaging for radiotherapy dosimetry.Radiother Oncol. 2008 Sep;88(3):289-309. doi: 10.1016/j.radonc.2008.07.008. Epub 2008 Aug 14. Radiother Oncol. 2008. PMID: 18706727 Review.
-
Estimating dose delivery accuracy in stereotactic body radiation therapy: A review of in-vivo measurement methods.Radiother Oncol. 2020 Aug;149:158-167. doi: 10.1016/j.radonc.2020.05.014. Epub 2020 May 19. Radiother Oncol. 2020. PMID: 32416282 Review.
Cited by
-
Error detection for radiotherapy planning validation based on deep learning networks.J Appl Clin Med Phys. 2024 Aug;25(8):e14372. doi: 10.1002/acm2.14372. Epub 2024 May 6. J Appl Clin Med Phys. 2024. PMID: 38709158 Free PMC article.
-
A Thorough Review of the Clinical Applications of Artificial Intelligence in Lung Cancer.Cancers (Basel). 2025 Mar 4;17(5):882. doi: 10.3390/cancers17050882. Cancers (Basel). 2025. PMID: 40075729 Free PMC article. Review.
-
"Under the hood": artificial intelligence in personalized radiotherapy.BJR Open. 2024 Jul 16;6(1):tzae017. doi: 10.1093/bjro/tzae017. eCollection 2024 Jan. BJR Open. 2024. PMID: 39104573 Free PMC article. Review.
-
Development of a deep learning-based error detection system without error dose maps in the patient-specific quality assurance of volumetric modulated arc therapy.J Radiat Res. 2023 Jul 18;64(4):728-737. doi: 10.1093/jrr/rrad028. J Radiat Res. 2023. PMID: 37177789 Free PMC article.
-
Detection of the failed-tolerance causes of electronic-portal-imaging-device-based in vivo dosimetry using machine learning for volumetric-modulated arc therapy: A feasibility study.Phys Imaging Radiat Oncol. 2025 May 17;34:100785. doi: 10.1016/j.phro.2025.100785. eCollection 2025 Apr. Phys Imaging Radiat Oncol. 2025. PMID: 40491759 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical